Shares of healthcare products company West Pharmaceutical Services (NYSE:WST) fell 34.9% in the afternoon session after the ...

Q4 2024 Earnings Call Transcript February 13, 2025 West Pharmaceutical Services, Inc. beats earnings expectations. Reported ...

Following the earnings announcement, WST stock plummeted 38% due to its disappointing guidance. Over a broader timeframe, its ...

West Pharmaceutical Services forecast full-year profit and revenue below Wall Street estimates on Thursday due to a strong ...

For 2025, West Pharmaceutical guided for sales between $2.88 billion and $2.91 billion as well as adjusted earnings per-share in the range of $6 and $6.20. Analysts polled by FactSet expected $3.04 ...

West Pharmaceutical reported Q4 earnings and revenue above expectations but issued a weak 2025 forecast. William Blair ...

We recently compiled a list of the Weak Earnings, Outlook Drag Shares of These 10 Firms on Thursday. In this article, we are ...

West Pharmaceutical (WST) is down -31.7%, or -$102.06 to $220.22.Maximize Your Portfolio with Data Driven Insights:Leverage the power of ...

(WST) on Thursday reported fourth-quarter profit of $130.1 million. The Exton, Pennsylvania-based company said it had net ...

In its fourth quarter 2024 investor letter, Conestoga Capital Advisors emphasized stocks such as West Pharmaceutical Services, Inc. (NYSE:WST). West Pharmaceutical Services, Inc. (NYSE:WST ...

We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions.